Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration.
about
Silver and gold nanoparticles exposure to in vitro cultured retina--studies on nanoparticle internalization, apoptosis, oxidative stress, glial- and microglial activityNanoparticles for brain drug deliveryApplied nanotoxicologyComparative absorption, distribution, and excretion of titanium dioxide and zinc oxide nanoparticles after repeated oral administrationTraffic-related air pollution and brain developmentA comparison between sphere and rod nanoparticles regarding their in vivo biological behavior and pharmacokinetics.In vitro and in vivo interactions of selected nanoparticles with rodent serum proteins and their consequences in biokineticsGold- and silver nanoparticles affect the growth characteristics of human embryonic neural precursor cells.Assessment of ZnO and SiO2 nanoparticle permeability through and toxicity to the blood-brain barrier using Evans blue and TEMAltered characteristics of silica nanoparticles in bovine and human serum: the importance of nanomaterial characterization prior to its toxicological evaluation.Influence of gold, silver and gold-silver alloy nanoparticles on germ cell function and embryo development.Size dependent translocation and fetal accumulation of gold nanoparticles from maternal blood in the rat.Influence of dendritic polyglycerol sulfates on knee osteoarthritis: an experimental study in the rat osteoarthritis model.Acute hematologic, hepatologic, and nephrologic changes after intraperitoneal injections of 18 nm gold nanoparticles in hamsters.Bidirectional Transfer Study of Polystyrene Nanoparticles across the Placental Barrier in an ex Vivo Human Placental Perfusion Model.Synthesis of Gold Nanoparticles with Buffer-Dependent Variations of Size and Morphology in Biological BuffersIn vivo human time-exposure study of orally dosed commercial silver nanoparticles.Air-blood barrier translocation of tracheally instilled gold nanoparticles inversely depends on particle sizeDiverse Applications of Nanomedicine.Interactions of engineered nanoparticles with organs protected by internal biological barriers.Engineered nanomaterial risk. Lessons learnt from completed nanotoxicology studies: potential solutions to current and future challenges.Inorganic nanoparticles based contrast agents for X-ray computed tomography.Bridge over troubled waters: understanding the synthetic and biological identities of engineered nanomaterials.Metal-based nanoparticle interactions with the nervous system: the challenge of brain entry and the risk of retention in the organism.Molecularly stabilised ultrasmall gold nanoparticles: synthesis, characterization and bioactivity.Advantages and risks of nanotechnologies in cancer patients and occupationally exposed workers.Pharmacokinetics of metallic nanoparticles.Nanoparticles and the blood-brain barrier: advancing from in-vitro models towards therapeutic significance.Effect of particle agglomeration in nanotoxicology.Development of nanotoxicology: implications for drug delivery and medical devices.Health implications of engineered nanoparticles in infants and children.Nanoparticle dosage-a nontrivial task of utmost importance for quantitative nanosafety research.A comprehensive framework for evaluating the environmental health and safety implications of engineered nanomaterials.Effects of food-borne nanomaterials on gastrointestinal tissues and microbiota.Approaches to Develop Alternative Testing Strategies to Inform Human Health Risk Assessment of Nanomaterials.Paracrine signalling of inflammatory cytokines from an in vitro blood brain barrier model upon exposure to polymeric nanoparticles.Assessing orally bioavailable commercial silver nanoparticle product on human cytochrome P450 enzyme activity.Internalization of SiO₂ nanoparticles by alveolar macrophages and lung epithelial cells and its modulation by the lung surfactant substitute Curosurf.Effects of silver nanoparticles on the liver and hepatocytes in vitro.Evidence and uptake routes for Zinc oxide nanoparticles through the gastrointestinal barrier in Xenopus laevis.
P2860
Q21131960-53F93E0E-B3BB-4427-A761-02B888275A3BQ21285117-960A48F8-1E4D-47B5-ACC9-D6B2688BD6F7Q23911868-EC583795-8B52-4CCE-BC79-925BFCA17A16Q28396482-AF469FF0-00F8-48C5-9130-A5EEFCCAC531Q28604124-AC39D05B-1FF1-4BC6-B9AF-15BCB85E8829Q33830003-8BB66ADF-DCD6-4163-93C1-6FCC216BE6F5Q34463566-A66E2D23-33F8-492D-8F61-16E1FCFDECC4Q34625659-50A2259B-95D9-4266-B2EF-7B5672154F4BQ34787906-C31DE698-93FE-4984-905B-16F0D378DF2DQ35037265-E6300721-0FD3-48FB-AF1F-55072323FFE6Q35184136-D8AE70F0-2939-4C27-AA87-924E7DACBBA3Q35653525-A27B40E2-6AE7-4860-A397-97CBCA0D4C8CQ35869782-77653D0C-C8BC-499D-B874-1BE391BF2DEFQ36063720-25092A1C-6E7B-4E34-8E65-D5FE8EC41FC6Q36350868-92D6F81E-4C0A-45D1-B7DA-EC040979573AQ36547550-31DC4912-926E-4354-8036-F465BB7C4A25Q37423403-8EB79690-908C-4962-B1DD-FC1F5C021F5DQ37651373-43D890A4-5B26-497C-B795-F13219C42F93Q37728142-9E192246-10FA-42B8-8B12-DC8EA8B7D8BCQ38055450-1E7B5B12-48B4-49DA-B49E-04865DD9BC2EQ38057778-55A9A3F8-C313-4480-8827-3F9A00681463Q38062896-D5B932E6-0347-46EB-AA03-27163CB23D5EQ38075542-FC948F64-621A-4204-97A4-072564582DB1Q38097386-A13557CC-B59C-4B22-9C6D-86BEFA64E301Q38112603-CE8CBB5E-CF93-4DAB-AE44-6EC6122A066DQ38207696-33594587-4135-453E-B3E8-11F110978FC2Q38260360-2C106880-E06B-460E-849E-F5AFA2F3B017Q38275050-2D80CFA6-6B5B-4512-82D8-1EEB0038E167Q38331210-BD4D9994-A089-4D9C-9680-F4ADDA41F535Q38538525-ECD8781E-5C4C-4F8C-9AA9-F04A5A0A5D0AQ38562639-642C26D2-6AD1-4DD1-91D0-D18EB12FB42DQ38641001-637A1FB5-C11F-4D13-9D0F-C73B16809C5DQ38665194-3E1EC845-FD7E-4BC8-99F6-0678F4BDA545Q38761757-7A168C4A-379D-4309-B387-D0522A52D6C3Q38855212-F3359370-4A12-45B6-9087-9C17682A0484Q39066676-AF6FF832-3268-47CF-845F-9C7E4C627587Q39142964-DE201714-F5F7-4BE7-9126-940B70C6A4ABQ39216590-CB1481BA-984E-48E3-BE56-2FDB204FEE41Q39255450-7924E223-E0A4-48B7-B263-942F7CA31BF2Q39385907-B1303CB9-7E81-49B4-A3BD-E76A26037368
P2860
Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Size and surface charge of gol ...... ans after oral administration.
@ast
Size and surface charge of gol ...... ans after oral administration.
@en
type
label
Size and surface charge of gol ...... ans after oral administration.
@ast
Size and surface charge of gol ...... ans after oral administration.
@en
prefLabel
Size and surface charge of gol ...... ans after oral administration.
@ast
Size and surface charge of gol ...... ans after oral administration.
@en
P2093
P2860
P859
P1433
P1476
Size and surface charge of gol ...... gans after oral administration
@en
P2093
Alexander Wenk
Carsten Schleh
Günter Schmid
Jens Lipka
Manuela Semmler-Behnke
Martin Schäffler
Stephanie Hirn
P2860
P356
10.3109/17435390.2011.552811
P577
2011-02-10T00:00:00Z